Skip to content

Evaluation on the acceptance of a biocompatible adhesive patch for use with a new articulation detection method.

Evaluation on the acceptance of a biocompatible adhesive patch for use with a new articulation detection method.

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
DRKS
Registry ID
DRKS00039686
Enrollment
30
Registered
2026-03-31
Start date
2026-09-30
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Z90.0

Interventions

Group 1: Prospective, exploratory data collection investigating the acceptance and skin tolerability of biocompatible adhesive patches in individuals with aphonia or severe dysphonia, particularly aft

Sponsors

Altavo GmbH
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Aphonia or severe dysphonia, e.g. following total or partial laryngectomy (but not limited to this); > 6 months after primary tumor surgery or radiotherapy for Phase I; > 6 weeks after radiotherapy for Phase II; Use of a voice prosthesis or any other form of voice rehabilitation does not preclude inclusion; Written informed consent to participate in the evaluation; Sufficient proficiency in standard German (e.g. native speaker with completed language acquisition).

Exclusion criteria

Exclusion criteria: Current suspicion of tumor recurrence or medical complications; Hearing impairment relevant to speech production; Acute psychiatric disorder (e.g. major depression) or doubts about the ability to provide informed consent (e.g. dementia); Acute or chronic dermatological conditions in the orofacial region (excluding post-radiation skin changes) that may contraindicate the use of the adhesive patch or interfere with data evaluation; Poor general health condition that, in the investigator’s judgment, precludes study participation; Limited reading ability due to illiteracy or a native language other than German (relevant for information and documentation) Pronounced, non-modifiable facial hair (e.g. beard in the cheek area); Concurrent participation in another study; Active second primary malignancy

Design outcomes

Primary

MeasureTime frame
Acceptance and skin tolerability of the adhesive patches, assessed by DLQI and physician-rating.

Secondary

MeasureTime frame
Comparison of different wearing intervals, documentation of use in a wear diary, change in DLQI, and course of skin reactions.

Countries

Germany

Contacts

Public ContactAndreas Müller

SRH Waldklinikum Gera GmbH

andreas.mueller@srh.de+49 365 828 2651

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Aug 10, 2026